The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

BTOG 2020 | Importance of occupational therapy for patients in early clinical trials

Name: Importance of occupational therapy for patients in early clinical trials
Uploaded: 2020-01-30T00:00:00Z
Duration: 1 min 41 s
Description: Alastair Greystoke, MBChB, MSc, PhD, MRCP, Northern Institute for Cancer Research, Newcastle University, Newcastle, UK, outlines the need for occupational therapists during early clinical trials in order to maintain patient’s fitness during their wait for new therapy. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.

Alastair Greystoke • 30 Jan 2020

BTOG 2020

General Lung Cancer

Alastair Greystoke, MBChB, MSc, PhD, MRCP, Northern Institute for Cancer Research, Newcastle University, Newcastle, UK, outlines the need for occupational therapists during early clinical trials in order to maintain patient’s fitness during their wait for new therapy. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.